Supplementary Figure 4 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment

Supplementary Figure 4 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment

<p>Figure S4 shows the gating strategy of monocytes sorted from BAFF-expressing and control tumors</p>

保存先:

書誌詳細
第一著者:	Wei Liu (20030) (author)
その他の著者:	Paweł Stachura (8480817) (author), Haifeng C. Xu (7373933) (author), Renáta Váraljai (15194397) (author), Prashant Shinde (3707917) (author), Nikkitha Umesh Ganesh (15194400) (author), Matthias Mack (148002) (author), Anke Van Lierop (15194403) (author), Anfei Huang (461244) (author), Balamurugan Sundaram (440602) (author), Karl S. Lang (8444004) (author), Daniel Picard (14938665) (author), Ute Fischer (15194406) (author), Marc Remke (3508145) (author), Bernhard Homey (31953) (author), Alexander Roesch (2416078) (author), Dieter Häussinger (15194409) (author), Philipp A. Lang (7373936) (author), Arndt Borkhardt (2891) (author), Aleksandra A. Pandyra (8444013) (author)
出版事項:	2025
主題:	Cancer Tumor Biology Immuno-oncology Immunology Cytokines Myeloid-derived suppressor cells NK cells Tumor immunology animal models Tumor-associated macrophages Skin Cancers Melanoma Tumor Microenvironment Cytokines and the microenvironment
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Supplementary Figure 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Figure 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Figure 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Figure 5 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Figure 6 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Figure7 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Table 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Table 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary Table 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
著者:: Wei Liu (20030)
出版事項: (2025)

Supplementary figures and tables FTS1 from Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
著者:: Daniel S. Green (15047598)
出版事項: (2025)

Supplementary Figures SF1-SF9 from Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
著者:: Robin M. Hallett (15037427)
出版事項: (2025)

Supplementary Tables ST1-ST6 from Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
著者:: Robin M. Hallett (15037427)
出版事項: (2025)

Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
著者:: Sonia A. Patel (15055688)
出版事項: (2025)

Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
著者:: Sonia A. Patel (15055688)
出版事項: (2025)

Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
著者:: Sonia A. Patel (15055688)
出版事項: (2025)

Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
著者:: Sonia A. Patel (15055688)
出版事項: (2025)

Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
著者:: Sonia A. Patel (15055688)
出版事項: (2025)

Figure S1 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
著者:: Dahihm Kim (16546203)
出版事項: (2025)

Figure S2 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
著者:: Dahihm Kim (16546203)
出版事項: (2025)

Figure S3 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
著者:: Dahihm Kim (16546203)
出版事項: (2025)

Figure S4 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
著者:: Dahihm Kim (16546203)
出版事項: (2025)

Figure S5 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
著者:: Dahihm Kim (16546203)
出版事項: (2025)

Table S1 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
著者:: Dahihm Kim (16546203)
出版事項: (2025)

Table S3 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
著者:: Dahihm Kim (16546203)
出版事項: (2025)

Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma
著者:: Alexander N. Shoushtari (15023909)
出版事項: (2025)

Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
著者:: Min Wu (14962986)
出版事項: (2025)

Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
著者:: Min Wu (14962986)
出版事項: (2025)

Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
著者:: Min Wu (14962986)
出版事項: (2025)

Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
著者:: Min Wu (14962986)
出版事項: (2025)

Supplementary Figures from Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
著者:: Defne Bayik (14961098)
出版事項: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
著者:: Hansol Lee (15054787)
出版事項: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
著者:: Hansol Lee (15054787)
出版事項: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
著者:: Hansol Lee (15054787)
出版事項: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
著者:: Hansol Lee (15054787)
出版事項: (2025)

Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases
著者:: James S. Wilmott (15008931)
出版事項: (2025)

Supplementary Tables S1-7 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases
著者:: James S. Wilmott (15008931)
出版事項: (2025)

Supplementary file 1_Single-cell transcriptomics identifies FOSL1-regulated IGFBP3+ melanoma subtype as a neuro-immunoregulatory signaling hub facilitating tumor progression.docx
著者:: Wenjia Ge (22687361)
出版事項: (2025)

Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
著者:: Jonathan M.J. Derry (16648337)
出版事項: (2025)

Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
著者:: Jonathan M.J. Derry (16648337)
出版事項: (2025)

Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
著者:: Jonathan M.J. Derry (16648337)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_dh68s1apjrcmojhi8vukb3fgp5